Adial Pharmaceuticals Stock (NASDAQ: ADIL) stock price, news, charts, stock research, profile.
Open | $1.420 |
Close | $1.330 |
Volume / Avg. | 84.269K / 3.940M |
Day Range | 1.310 - 1.430 |
52 Wk Range | 0.765 - 14.000 |
Market Cap | $2.279M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 11.17% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adial Pharmaceuticals (NASDAQ: ADIL) through any online brokerage.
Other companies in Adial Pharmaceuticals’s space includes: Processa Pharma (NASDAQ:PCSA), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Palisade Bio (NASDAQ:PALI) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
The latest price target for Adial Pharmaceuticals (NASDAQ: ADIL) was reported by Brookline Capital on Tuesday, July 11, 2023. The analyst firm set a price target for 6.00 expecting ADIL to rise to within 12 months (a possible 337.96% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $1.37 last updated Today at March 28, 2024 at 5:51 PM EDT.
There are no upcoming dividends for Adial Pharmaceuticals.
Adial Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Adial Pharmaceuticals.
Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.